Cargando…

182. Appropriateness of Treatment Duration for S. aureus Bacteremia (SAB)

BACKGROUND: An algorithm-based guide to optimal treatment duration in staphylococcus bacteremia demonstrated a non-inferior rate of clinical success compared with standard of care. The purpose of this descriptive study was to assess appropriateness of staphylococcus bacteremia duration of therapy ac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Griebe, Kristin, Kenney, Rachel, Davis, Susan L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809680/ http://dx.doi.org/10.1093/ofid/ofz360.257

Ejemplares similares

Complicated Staphylococcus aureus Bacteremia (SAB) Is Associated with Genetic Variation in GLS2
por: Fowler, Vance, et al.
Publicado: (2017)

1071. Impact of Standard vs. Prolonged Courses of Antibiotics for the Treatment of Uncomplicated Staphylococcus aureus Bacteremia (SAB) in Patients With Hematologic Malignancies
por: Cheung, Edna, et al.
Publicado: (2018)

1079. When Does a Trans-Esophageal Echocardiogram (TEE) Change Management of Staphylococcus aureus Bacteremia (SAB)?
por: Lam, John, et al.
Publicado: (2018)

889. Impact of an Infectious Disease Telehealth (IDt) Service on S. aureus Bacteremia (SAB) Outcomes in 15 Small Community Hospitals
por: Gabrellas, Alithea D, et al.
Publicado: (2019)

637. Β-Lactam (BL) Antibiotics Promote an IL-1β Response in Patients with Staphylococcus aureus Bacteremia (SaB)
por: Volk, Cecilia, et al.
Publicado: (2018)

764 Risk Factors for Failure of Outpatient Parenteral Antimicrobial Therapy (OPAT) in the Management of Staphylococcus aureus Bacteremia (SAB)
por: Veillette, John, et al.
Publicado: (2014)

412. Host Response Biomarkers Predict Clinical Failure in Patients with Staphylococcus aureus Bacteremia (SAB) Treated with Flucloxacillin (FLU) or Vancomycin (VAN)
por: Aycock, Anna, et al.
Publicado: (2019)

1220. Impact of Mandatory Infectious Diseases Consultation on the Use of Core Measures and Mortality in Staphylococcus aureus Bacteremia (SAB) at an Academic Medical Center
por: Gancher, Elizabeth, et al.
Publicado: (2018)

2531. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Ceftobiprole Dosing Regimens for Patients with Staphylococcus aureus Bacteremia (SAB)
por: Bhavnani, Sujata M, et al.
Publicado: (2023)

188. Plan PDD (patient directed discharge): Oral contingency plans for people who inject drugs (PWID) with Staphylococcus aureus bacteremia (SAB) who leave the hospital prematurely
por: Duffield, Olivia, et al.
Publicado: (2023)

182. Missed Opportunities to Discontinue Unnecessary Vancomycin During Pharmacist Therapeutic Monitoring
por: Medler, Corey J, et al.
Publicado: (2020)

Sab
por: Gómez de Avellaneda y Arteaga, Gertrudis, 1814-1873
Publicado: (1976)

1019. Treatment Outcomes for Enterococcus faecium Bacteremia in Solid-Organ Transplant Patients: Implications for Daptomycin
por: Mercuro, Nicholas J, et al.
Publicado: (2018)

444. The disruptive effects of COVID-19 on the incidence of hospital acquired staphylococcus aureus bacteremia (HA-SAB) and its associated factors with mortality in a tertiary teaching hospital in an upper-middle income country
por: Ponnampalavanar, Sasheela Sri La Sri, et al.
Publicado: (2023)

Sab : novela
por: Gómez de Avellaneda y Arteaga, Gertrudis, 1814-1873
Publicado: (1970)

158. The Effect of Insurance Coverage on Appropriate Selection of Hospital Discharge Antibiotics for Staphylococcus aureus Bacteremia
por: McHale, Thomas, et al.
Publicado: (2018)

Sab : novela original
por: Gómez de Avellaneda y Arteaga, Gertrudis, 1814-1873
Publicado: (1963)

Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia (SAB7): study protocol for a randomized controlled trial
por: Thorlacius-Ussing, Louise, et al.
Publicado: (2019)

191. Appropriateness of Empiric Antibiotics for Enterobacteriaceae Bacteremia
por: Smith, Brandon J, et al.
Publicado: (2019)

Uncomplicated Staphylococcus aureus Bacteremia Treatment Duration and Outcomes at an Academic Medical Center
por: Taupin, Daniel, et al.
Publicado: (2020)

LB2302. Ceftobiprole Compared to Daptomycin With or Without Optional Aztreonam for the Treatment of Complicated Staphylococcus aureus (SAB): Results of a Phase 3, Randomized, Double-Blind Trial (ERADICATE)
por: Holland, Thomas L, et al.
Publicado: (2022)

2099. Catheter-related Staphylococcus aureus Bacteremia and Septic Thrombosis: The Role of Anticoagulation and Duration of Intravenous Antibiotic Therapy
por: Dib, Rita Wilson, et al.
Publicado: (2018)

1065. Evaluation of a Staphylococcus aureus Bacteremia Treatment Checklist
por: Soukup, Hailey, et al.
Publicado: (2018)

117. Adjunctive Daptomycin in the Treatment of staphylococcus Aureus Bacteremia
por: Cheng, Matthew P, et al.
Publicado: (2020)

SIR-SAB-RFB Program
por: Delgado, RM
Publicado: (1984)

182. Impact of Rapid Identification and Phenotypic Results on Clinical, Economic, Antimicrobial Stewardship Outcomes in Patients with Gram-Negative Bacteremia
por: Shoop, Harold, et al.
Publicado: (2022)

195. Duration of Therapy for Streptococcal Bacteremia
por: Boulos, John M, et al.
Publicado: (2021)

SAbDab in the age of biotherapeutics: updates including SAbDab-nano, the nanobody structure tracker
por: Schneider, Constantin, et al.
Publicado: (2021)

Treatment of Staphylococcus aureus Bacteremia in Children: Is Intravenous Therapy Always Needed?
por: Dona, Daniele, et al.
Publicado: (2017)

227. Staphylococcus aureus bacteremia: back to normal
por: Pedromingo Kus, Miguel Sebastian, et al.
Publicado: (2023)

150. Urinary Tract-Associated Gram-Negative Bacteremia: Impact of Treatment Duration
por: Badwal, Jasmin K, et al.
Publicado: (2019)

97. The Utilization of Echocardiography in Children with Staphylococcus aureus Bacteremia
por: Bui, Richard, et al.
Publicado: (2023)

1059. Staphylococcus aureus Bacteremia Treatment: Results From Pilot Surveillance in Four US States
por: Kabbani, Sarah, et al.
Publicado: (2018)

Staphylococcus aureus Bacteremia in Children: The Effect of Methicillin Resistance
por: Hamdy, Rana F, et al.
Publicado: (2017)

1060. Risk Factors for Recurrent Staphylococcus aureus Bacteremia
por: Choi, Seong-Ho, et al.
Publicado: (2018)

SAbDab: the structural antibody database
por: Dunbar, James, et al.
Publicado: (2014)

1817. Characteristics and Outcomes in Patients with Staphylococcus lugdunensis Bacteremia Compared with Staphylococcus aureus and Staphylococcus epidermidis Bacteremia
por: Yukawa, Satomi, et al.
Publicado: (2022)

The Effect of Insurance on Appropriate Hospital Discharge Antibiotics for Patients With Staphylococcus aureus Bacteremia
por: McHale, Thomas, et al.
Publicado: (2020)

Management of Staphylococcus aureus bacteraemia (SAB) in the oncology patient: Further evidence supports prompt removal of central venous catheters and shorter duration of intravenous antimicrobial therapy
por: Dunne, Colum P., et al.
Publicado: (2020)

229. The Role of Antimicrobial Stewardship Program on Appropriate Use, Dose, and Duration of Vancomycin Treatment
por: Kaplun, Olga, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_h664i2e9re1g84caf7ka018c56